These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 15053800

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Proteomics techniques and their application in haemato-oncologic malignancies].
    Zelená J, Hájek R.
    Cas Lek Cesk; 2007; 146(7):586-92. PubMed ID: 17722845
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H, Zhu H, Zeng S, Li Y, Yang H, Shen L, Chen J, Zeng L, Fan J, Li X, Gong Y, Shen H.
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [Abstract] [Full Text] [Related]

  • 7. Proteomic analysis of multiple myeloma: current status and future perspectives.
    Ge F, Bi LJ, Tao SC, Xu XD, Zhang ZP, Kitazato K, Zhang XE.
    Proteomics Clin Appl; 2011 Feb; 5(1-2):30-7. PubMed ID: 21280235
    [Abstract] [Full Text] [Related]

  • 8. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Yu CY, Lu FJ, Chow LP.
    J Proteome Res; 2005 Feb; 4(6):2062-9. PubMed ID: 16335951
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical cancer proteomics: promises and pitfalls.
    Alaiya A, Al-Mohanna M, Linder S.
    J Proteome Res; 2005 Feb; 4(4):1213-22. PubMed ID: 16083271
    [Abstract] [Full Text] [Related]

  • 12. Cancer proteomics: Serum diagnostics for tumor marker discovery.
    Rai AJ, Chan DW.
    Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Proteomic technology and its biomedical applications.
    Lau AT, He QY, Chiu JF.
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):965-75. PubMed ID: 14614532
    [Abstract] [Full Text] [Related]

  • 17. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J, Jacot W, Lhermitte L, Boulle N, Maudelonde T, Mangé A.
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [Abstract] [Full Text] [Related]

  • 18. [Present possibilities and future development of clinical proteomics].
    Lehmann S, Dupuy A, Peoc'h K, Roche S, Baudin B, Quillard M, Berger F, Briand G, Chwetzoff S, Dine G, Gonzalo P, Dastugue B, Sève M, Siest G, Beaudeux JL.
    Ann Biol Clin (Paris); 2007 Jun; 65(5):463-71. PubMed ID: 17913666
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.